Nuveen, LLC Tenaya Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 226,202 shares of TNYA stock, worth $108,576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
226,202Holding current value
$108,576% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
97Shares Held
41.9MCall Options Held
74.3KPut Options Held
192K-
Column Group LLC San Francisco, CA9.4MShares$4.51 Million24.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$3.23 Million0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$1.96 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$1.96 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$1.08 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $19.9M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...